Literature DB >> 25583891

Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort.

Wouter van Dijk1, Wan Tan2, Pei Li3, Best Guo2, Summer Li2, Andrea Benedetti3, Jean Bourbeau4.   

Abstract

PURPOSE: The way in which spirometry is interpreted can lead to misdiagnosis of chronic obstructive pulmonary disease (COPD) resulting in inappropriate treatment. We compared the clinical relevance of 2 criteria for defining a low ratio of forced expiratory volume in 1 second to forced vital capacity (FEV1/FVC): the fixed ratio and the lower limit of normal.
METHODS: We analyzed data from the cross-sectional phase of the population-based Canadian Cohort of Obstructive Lung Disease (CanCOLD) study. We determined associations of the spirometric criteria for airflow limitation with patient-reported adverse outcomes, including respiratory symptoms, disability, health status, exacerbations, and cardiovascular disease. Sensitivity analyses were used to explore the impact of age and severity of airflow limitation on these associations.
RESULTS: We analyzed data from 4,882 patients aged 40 years and older. The prevalence of airflow limitation was 17% by fixed ratio and 11% by lower limit of normal. Patients classified as having airflow limitation by fixed ratio only had generally small, nonsignificant increases in the odds of adverse outcomes. Patients having airflow limitation based on both fixed ratio and lower limit of normal had larger, significant increases in odds. But strongest associations were seen for patients who had airflow limitation by both fixed ratio and lower limit of normal and also had a low FEV1, defined as one less than 80% of the predicted value.
CONCLUSIONS: Our results suggest that use of the fixed ratio alone may lead to misdiagnosis of COPD. A diagnosis established by both a low FEV1/FVC (according to fixed ratio and/or lower limit of normal) and a low FEV1 is strongly associated with clinical outcomes. Guidelines should be reconsidered to require both spirometry abnormalities so as to reduce overdiagnosis of COPD.
© 2015 Annals of Family Medicine, Inc.

Entities:  

Keywords:  COPD; FEV1; clinical relevance; diagnosis; fixed ratio; lower limit of normal; lung diseases; spirometry

Mesh:

Year:  2015        PMID: 25583891      PMCID: PMC4291264          DOI: 10.1370/afm.1714

Source DB:  PubMed          Journal:  Ann Fam Med        ISSN: 1544-1709            Impact factor:   5.166


  25 in total

1.  GOLD stage I is not a COPD risk factor.

Authors:  Paul L Enright
Journal:  Thorax       Date:  2007-12       Impact factor: 9.139

2.  The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands.

Authors:  Lowie E G W Vanfleteren; Frits M E Franssen; Geertjan Wesseling; Emiel F M Wouters
Journal:  Respir Med       Date:  2012-02-19       Impact factor: 3.415

3.  Can age and sex explain the variation in COPD rates across large urban cities? A population study in Canada.

Authors:  W C Tan; J Bourbeau; J M FitzGerald; R Cowie; K Chapman; P Hernandez; S A Buist; D D Sin
Journal:  Int J Tuberc Lung Dis       Date:  2011-12       Impact factor: 2.373

4.  Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care.

Authors:  Kylie Hill; Roger S Goldstein; Gordon H Guyatt; Maria Blouin; Wan C Tan; Lori L Davis; Diane M Heels-Ansdell; Marko Erak; Pauline J Bragaglia; Itamar E Tamari; Richard Hodder; Matthew B Stanbrook
Journal:  CMAJ       Date:  2010-04-06       Impact factor: 8.262

5.  Determinants of spirometry use and accuracy of COPD diagnosis in primary care.

Authors:  Min J Joo; David H Au; Marian L Fitzgibbon; Joanne McKell; Todd A Lee
Journal:  J Gen Intern Med       Date:  2011-06-29       Impact factor: 5.128

Review 6.  Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review.

Authors:  Firdaus A A Mohamed Hoesein; Pieter Zanen; Jan-Willem J Lammers
Journal:  Respir Med       Date:  2011-02-05       Impact factor: 3.415

7.  Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction.

Authors:  M P Swanney; G Ruppel; P L Enright; O F Pedersen; R O Crapo; M R Miller; R L Jensen; E Falaschetti; J P Schouten; J L Hankinson; J Stocks; P H Quanjer
Journal:  Thorax       Date:  2008-09-11       Impact factor: 9.139

8.  Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD.

Authors:  P-O Bridevaux; M W Gerbase; N M Probst-Hensch; C Schindler; J-M Gaspoz; T Rochat
Journal:  Thorax       Date:  2008-05-27       Impact factor: 9.139

9.  Spirometry utilization for COPD: how do we measure up?

Authors:  Meilan K Han; Min Gayles Kim; Russell Mardon; Phil Renner; Sean Sullivan; Gregory B Diette; Fernando J Martinez
Journal:  Chest       Date:  2007-06-05       Impact factor: 9.410

10.  "GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study".

Authors:  Gülmisal Güder; Susanne Brenner; Christiane E Angermann; Georg Ertl; Matthias Held; Alfred P Sachs; Jan-Willem Lammers; Pieter Zanen; Arno W Hoes; Stefan Störk; Frans H Rutten
Journal:  Respir Res       Date:  2012-02-06
View more
  29 in total

1.  Overdiagnosis of COPD: precise definitions and proposals for improvement.

Authors:  Alberto Fernández-Villar; Joan B Soriano; José Luis López-Campos
Journal:  Br J Gen Pract       Date:  2017-04       Impact factor: 5.386

2.  Does Low FEV1 in Addition to Fixed Ratio and/or Lower Limit of Normal of FEV1/FVC Improve Prediction of Mortality in COPD? The NHANES-III-linked-mortality Cohort.

Authors:  Yewande E Odeyemi; O'Dene Lewis; Julius Ngwa; Kristen Dodd; Richard F Gillum; Alem Mehari
Journal:  J Natl Med Assoc       Date:  2018-07-29       Impact factor: 1.798

3.  The View of the Turkish Thoracic Society on the Report of the GOLD 2017 Global Strategy for the Diagnosis, Management, and Prevention of COPD.

Authors:  Nurdan Köktürk; Alev Gürgün; Elif Şen; Ali Kocabaş; Mehmet Polatlı; Sibel Atış Naycı; Lütfi Çöplü; Emel Tellioğlu; Funda Elmas; Ertürk Erdinç
Journal:  Turk Thorac J       Date:  2017-04-01

4.  Significance of FEV3/FEV6 in Recognition of Early Airway Disease in Smokers at Risk of Development of COPD: Analysis of the SPIROMICS Cohort.

Authors:  Nathan Yee; Daniela Markovic; Russell G Buhr; Spyridon Fortis; Mehrdad Arjomandi; David Couper; Wayne H Anderson; Robert Paine; Prescott G Woodruff; Meilan K Han; Fernando J Martinez; R Graham Barr; James M Wells; Victor E Ortega; Eric A Hoffman; Victor Kim; M Bradley Drummond; Russell P Bowler; Jeffrey L Curtis; Christopher B Cooper; Donald P Tashkin; Igor Z Barjaktarevic
Journal:  Chest       Date:  2021-11-10       Impact factor: 10.262

5.  The prognostic significance of lung function in stable heart failure outpatients.

Authors:  Louis Lind Plesner; Morten Dalsgaard; Morten Schou; Lars Køber; Jørgen Vestbo; Erik Kjøller; Kasper Iversen
Journal:  Clin Cardiol       Date:  2017-09-13       Impact factor: 2.882

6.  GOLD criteria overestimate airflow limitation in one-third of cases in the general Finnish population.

Authors:  Annette Kainu; Kirsi Timonen; Ari Lindqvist; Päivi Piirilä
Journal:  ERJ Open Res       Date:  2016-10-19

7.  What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study.

Authors:  Stefan Karrasch; Irene Brüske; Maia P Smith; Barbara Thorand; Cornelia Huth; Karl-Heinz Ladwig; Florian Kronenberg; Joachim Heinrich; Rolf Holle; Annette Peters; Holger Schulz
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-08-16

8.  Office-Based Case Finding for Chronic Obstructive Pulmonary Disease in Older Adults in Primary Care.

Authors:  Linda Lee; Tejal Patel; Loretta M Hillier; James Milligan
Journal:  Can Respir J       Date:  2016-06-22       Impact factor: 2.409

9.  Plasma Inflammatory Cytokine IL-4, IL-8, IL-10, and TNF-α Levels Correlate with Pulmonary Function in Patients with Asthma-Chronic Obstructive Pulmonary Disease (COPD) Overlap Syndrome.

Authors:  Ai-Xia Huang; Li-Wen Lu; Wen-Juan Liu; Mao Huang
Journal:  Med Sci Monit       Date:  2016-08-09

10.  Reference Values for Spirometry Derived Using Lambda, Mu, Sigma (LMS) Method in Korean Adults: in Comparison with Previous References.

Authors:  Bum Seak Jo; Jun Pyo Myong; Chin Kook Rhee; Hyoung Kyu Yoon; Jung Wan Koo; Hyoung Ryoul Kim
Journal:  J Korean Med Sci       Date:  2018-01-15       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.